Is AVEX a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for AEVEX Corp. (AVEX) rests on One-way attack drone procurement moving from experiment to program of record: AEVEX booked roughly ~$88.1 million of production orders for long-range precision strike systems announced in late July 2026, on top of a ~$50 million US Air Force award for advanced unmanned mission capabilities on June 30, 2026 and a ~$17.5 million follow-on in early July. The bear case rests on customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results. Analysts covering it publish targets from $13.00 to $45.00 against a $11.69 price, so even the professionals disagree by 124% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
AEVEX Corp. was founded in 2017 and runs two segments. Tactical Systems designs and builds attritable unmanned systems: the Phoenix Ghost loitering munition family (including the Disruptor and Dominator variants first revealed publicly when the Pentagon sent 121 units to Ukraine in April 2022), plus the Mako unmanned surface vessel shown at the Special Operations Forces trade show in May 2026, which the company rates at up to 50 knots. Global Solutions is the services half: airborne ISR, processing and exploitation of collected imagery, and in-theater manufacturing and sustainment close to the units using the hardware. Roughly ~78% of revenue comes from government customers, the company employs about ~650 people, and it says it has more than ~10,200 systems committed through the end of 2026. The investment picture is a fast-growing government supplier priced as a growth stock. Trailing twelve-month revenue reached about ~$697 million through June 2026 on net income of roughly ~$22.4 million (~$0.21 per share), and analysts now expect about ~$760 million of revenue for 2026, above the ~$600 million to ~$620 million management first guided before it raised the outlook with second-quarter results. Funded backlog was ~$356.6 million at March 31, 2026, about ~93% of which the company expected to convert to revenue over the remainder of the year, against an identified pipeline it puts at ~$8.2 billion. The offsets are structural rather than operational: Madison Dearborn Partners retains roughly ~79% of the voting power through a dual-class structure, the public float is small, and the stock has already traded between about ~$13.07 and ~$42.34 in its first months as a public company. The second quarter of 2026, the first full period reported as a public company, came in well ahead of expectations: EPS of ~$0.19 against a ~$0.07 consensus, revenue roughly double the year-earlier quarter, and a lifted full-year outlook. Orders kept coming. In September AEVEX was selected for a Defense Department SkyRange hypersonic test-support contract worth up to ~$92.2 million and unveiled Specter, a jet-powered modular autonomous aircraft, and RBC counts ~$175 million of funded orders and about ~$260 million of total bookings in the third quarter. The share price has moved the other way. By October 16, 2026 it had fallen to $15.59, with RBC pointing to the ~65% of 2026 revenue tied to Ukraine-related programs, defense budget uncertainty around the 2026 midterm elections, a crowded drone field, and a poorly received secondary offering soon after the IPO. RBC cut its target to $26 from $31 on October 12 while keeping an Outperform rating. Third-quarter results are expected around November 12, 2026.
The bull case: what would have to be true for $45.00
The most optimistic published target on AVEX is $45.00, +284.9% from the $11.69 price as of November 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. One-way attack drone procurement moving from experiment to program of record
AEVEX booked roughly ~$88.1 million of production orders for long-range precision strike systems announced in late July 2026, on top of a ~$50 million US Air Force award for advanced unmanned mission capabilities on June 30, 2026 and a ~$17.5 million follow-on in early July. These are repeat production buys rather than prototype contracts, which is what separates a supplier from a demonstrator. The pace continued after the summer: RBC tallies ~$175 million of funded orders in the third quarter, and the up to ~$92.2 million SkyRange award adds hypersonic test support to the mix.
2. Attritable economics fit the way the US now plans to fight
Loitering munitions are consumed on use, so demand scales with operations rather than with fleet replacement cycles. That gives AEVEX a recurring-consumption revenue shape more like ammunition than like airframes, and it is the reason the company can point to an identified opportunity set of roughly ~$8.2 billion against only ~$356.6 million of funded backlog at March 31, 2026. Revenue is also concentrated: about ~65% of 2026 revenue is tied to Ukraine-related programs, so the consumption that drives demand today is largely one customer's war.
3. The services segment converts hardware into an installed base
Global Solutions supplies the ISR collection, exploitation and in-theater manufacturing that sits around the hardware, which lengthens customer relationships and raises switching costs. It also smooths revenue, because services bill against task orders while Tactical Systems revenue arrives in production lots that can land unevenly across quarters.
4. Margin leverage on a scaling manufacturing base
Total revenue in the first quarter of 2026 was ~$216.7 million against ~$53.3 million a year earlier, a comparison that reflects the assembled scale of the group rather than organic growth alone, and second-quarter revenue roughly doubled year over year. Over the last twelve months gross margin was ~25.4% and operating margin ~10.2%, and the company is on track to double production capacity by the end of 2026. The question for 2027, when analysts expect revenue of about ~$914 million, is how much of that added volume drops through to operating margin as production rates rise.
The bear case: what would have to be true for $13.00
The most pessimistic published target is $13.00, +11.2% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks AEVEX Corp. is worth if the risks below bite instead of the drivers above.
Customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results. The dual-class structure leaves Madison Dearborn Partners with about ~79% of the voting power, which means public holders have essentially no say on capital allocation, board composition or a future secondary sale that could pressure the share price. The single biggest program risk is Ukraine: about ~65% of 2026 revenue is tied to Ukraine-related programs, and a ceasefire or a shift in US aid would leave a gap that new awards must fill in 2027. The trailing P/E of ~74x looks high because GAAP earnings are thin, though the forward multiple of about ~22x is far lower than at the IPO. Order lumpiness is real, since a single production lot can swing a quarter and funded backlog of ~$356.6 million covers well under a year of revenue. And as a 2026 IPO with a limited public float, the stock has already ranged from about ~$13.07 to ~$42.34, so drawdowns unrelated to fundamentals should be expected; the shares fell about 42% from their first trade to October 16, 2026, despite beating second-quarter estimates. Operating cash flow was also negative, about ~-$61 million over the last twelve months, as working capital grew with production.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding AVEX already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on AVEX
10 analysts cover AVEX, with an average target of $25.80 (+120.7% against $11.69) and a split of 10 buy, 1 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the AVEX forecast and price target page.
How is AVEX valued? (as of October 2026)
Snapshot for AVEX as of November 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$697 million through June 2026; Q2 roughly double the prior-year quarter
- Q2 2026 EPS: ~$0.19 vs ~$0.07 consensus
- Net income (TTM): ~$22.4 million, or ~$0.21 per share
- Margins (TTM): Gross ~25.4%, operating ~10.2%
- P/E trailing / forward: ~74x / ~22x at $15.59
- Revenue estimates: ~$760 million for 2026, ~$914 million for 2027
- Cash and debt: ~$215 million cash, ~$108 million debt
- Market capitalization: ~$1.1 billion (Yahoo Finance count)
AEVEX is profitable, which distinguishes it from most drone-adjacent listings, and at ~1.6x trailing sales and ~22x forward earnings it now trades well below the multiples of its April debut. The market is discounting the ~65% of 2026 revenue tied to Ukraine-related programs and the risk that 2027 does not grow as analysts expect. Third-quarter results, expected around November 12, 2026 (consensus ~$0.09 per share on ~$150 million of revenue), are the next read on bookings and the 2027 setup.
How do you decide if AVEX is a buy?
Whether AVEX is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold AVEX indirectly through an index or sector ETF before adding more.
What would change your mind on AVEX
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: One-way attack drone procurement moving from experiment to program of record stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the AVEX stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AVEX against your real portfolio and see your actual exposure before deciding.
Investing in AEVEX Corp. with AI
Connect the broker you already use and ask Walnut's AI how AVEX fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is AVEX a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on One-way attack drone procurement moving from experiment to program of record, with revenue (ttm) at ~$697 million through June 2026; Q2 roughly double the prior-year quarter. The bear case rests on customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results. Analysts covering it are spread from $13.00 to $45.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell AVEX?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $13.00, +11.2% from the $11.69 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for AVEX?
+
One-way attack drone procurement moving from experiment to program of record. AEVEX booked roughly ~$88.1 million of production orders for long-range precision strike systems announced in late July 2026, on top of a ~$50 million US Air Force award for advanced unmanned mission capabilities on June 30, 2026 and a ~$17.5 million follow-on in early July. The most optimistic analyst target on AVEX is $45.00, +284.9% from the $11.69 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for AVEX?
+
Customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results. The dual-class structure leaves Madison Dearborn Partners with about ~79% of the voting power, which means public holders have essentially no say on capital allocation, board composition or a future secondary sale that could pressure the share price. The single biggest program risk is Ukraine: about ~65% of 2026 revenue is tied to Ukraine-related programs, and a ceasefire or a shift in US aid would leave a gap that new awards must fill in 2027. The trailing P/E of ~74x looks high because GAAP earnings are thin, though the forward multiple of about ~22x is far lower than at the IPO. Order lumpiness is real, since a single production lot can swing a quarter and funded backlog of ~$356.6 million covers well under a year of revenue. And as a 2026 IPO with a limited public float, the stock has already ranged from about ~$13.07 to ~$42.34, so drawdowns unrelated to fundamentals should be expected; the shares fell about 42% from their first trade to October 16, 2026, despite beating second-quarter estimates. Operating cash flow was also negative, about ~-$61 million over the last twelve months, as working capital grew with production. The most pessimistic published target is $13.00, +11.2% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does AEVEX Corp. do?
+
Defence contractor behind the Phoenix Ghost loitering-munition family and AI-enabled intelligence, surveillance and reconnaissance services.
What would have to change for AVEX to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (One-way attack drone procurement moving from experiment to program of record) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (customer concentration is the dominant exposure: roughly ~78% of revenue comes from government buyers, so a continuing resolution, a program cancellation or a reprioritization inside the unmanned systems budget can move a full year of results) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does AVEX stand for and which exchange is it on?
+
AVEX is the ticker for AEVEX Corp., a defense technology contractor headquartered in Solana Beach, California. Its Class A common stock trades on the New York Stock Exchange, and the company went public on April 17, 2026.
What does AEVEX actually make?
+
Two things. Tactical Systems builds attritable unmanned systems, chiefly the Phoenix Ghost family of loitering munitions (with Disruptor and Dominator variants) and the Mako unmanned surface vessel. Global Solutions provides airborne intelligence, surveillance and reconnaissance, imagery exploitation, and in-theater manufacturing and sustainment.
Is AEVEX profitable?
+
Yes, on a trailing twelve-month basis. Net income was roughly ~$22.4 million, or about ~$0.21 per share, on revenue of roughly ~$697 million through June 2026, and the second quarter beat estimates with EPS of ~$0.19 against ~$0.07 expected. That works out to a trailing P/E near ~74x and a forward P/E near ~22x at the October 16, 2026 price of $15.59.
Walnut is informational, not investment advice, and gives no verdict on AVEX. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.